通过PI3K/AKT/MDM2通路对对子宫癌的影响
Dandan Xu1,2, Chenyang Hou3, Jianliang Chang3
1Central Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, 075000, Hebei Province, China.
Discover oncology
|June 23, 2025
概括
(CQ) 通过抑制PI3K/AKT/MDM2通路,对宫癌 (CC) 产生抗癌作用. 这种药物诱导细胞亡并减少CC细胞的增殖,提供了潜在的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 宫癌 (CC) 是女性癌症死亡的主要原因.
- (CQ) 是一种抗疟疾药物,因其潜在的抗癌性质而受到研究.
- 需要阐明CQ的抗CC机制,特别是涉及PI3K/AKT/MDM2通路,需要阐明.
研究的目的:
- 调查 (CQ) 对宫癌 (CC) 的抗癌作用.
- 阐明潜在的分子机制,重点关注PI3K/AKT/MDM2信号通路.
- 整合网络药理学与体外实验进行综合分析.
主要方法:
- 网络药理学确定了CC的CQ目标和关键节点.
- 在体外测试 (CCK-8,殖民地形成,伤口愈合) 评估了CQ对HeLa细胞增殖的影响.
- 流式细胞计和西式涂抹分析了亡和PI3K/AKT/MDM2通路蛋白质表达.
主要成果:
- CQ治疗抑制了HeLa细胞的活力,增殖和殖民地形成.
- 通过改变Bax,Bcl-2和分裂PARP表达,CQ诱导了亡.
- CQ抑制PI3K/AKT/MDM2信号通路,通过降低p-PI3K,p-AKT和p-MDM2水平来表明这一点.
结论:
- 氨酸显示出抗宫癌的活性.
- 在宫癌细胞中,CQ会诱导细胞亡.
- 抑制PI3K/AKT/MDM2通路是CQ抗癌作用的关键机制.
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K


